Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa
Maud Lemoine(St Mary's Hospital), Yusuke Shimakawa(Institut Pasteur), Karen Forrest(MRC Unit the Gambia), Appolinaire Sawadogo(West African Health Organisation), John Rwegasha(Muhimbili National Hospital), Marielle Bouyou(Université des Sciences de la Santé), Roger Sombié(Centre Hospitalier Universitaire Yalgado Ouédraogo), Gibril Ndow(MRC Unit the Gambia), Sosthène Somda(Centre Hospitalier Universitaire Yalgado Ouédraogo), Sulayman Bah(MRC Unit the Gambia), Delphine Napon(Centre Hospitalier Universitaire Yalgado Ouédraogo), Jin Un Kim(The Royal Free Hospital)
Cited by 31
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia
|Gut|2015|184
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study
|The Lancet Global Health|2016|182
Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa
|Journal of Clinical Microbiology|2015|89